GATA6 identifies an immune-enriched phenotype linked to favorable outcomes in patients with pancreatic cancer undergoing upfront surgery

This study underscores GATA6's role in distinguishing classical and basal-like pancreatic ductal adenocarcinoma (PDAC) phenotypes. Retrospective studies associate GATA6 immunohistochemistry (IHC) expression with survival outcomes, warranting prospective validation. In a prospective treatment-na...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Casper W.F. van Eijck, Francisco X. Real, Núria Malats, Disha Vadgama, Thierry van den Bosch, Michail Doukas, Casper H.J. van Eijck, Dana A. M. Mustafa
Formato: Artigo
Lenguaje:inglés
Publicado: 2024
Acceso en línea:https://doi.org/10.1016/j.xcrm.2024.101557
https://www.cell.com/article/S2666379124002490/pdf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!